Katz Steven J, Lantz Paula M, Janz Nancy K, Fagerlin Angela, Schwartz Kendra, Liu Lihua, Deapen Dennis, Salem Barbara, Lakhani Indu, Morrow Monica
Division of General Medicine, Department of Internal Medicine, University of Michigan, 300 N Ingalls, Ste 7E12, Box 0429, Ann Arbor, MI 48109-0429, USA.
J Clin Oncol. 2005 Aug 20;23(24):5526-33. doi: 10.1200/JCO.2005.06.217.
High rates of mastectomy and marked regional variations have motivated lingering concerns about overtreatment and failure to involve women in treatment decisions. We examined the relationship between patient involvement in decision making and type of surgical treatment for women with breast cancer.
All women with ductal carcinoma-in-situ and a 20% random sample of women with invasive breast cancer aged 79 years and younger who were diagnosed in 2002 and reported to the Detroit and Los Angeles Surveillance, Epidemiology, and End Results registries were identified and surveyed shortly after receipt of surgical treatment (response rate, 77.4%; n = 1,844).
Mean age was 60.1 years; 70.2% of the women were white, 18.0% were African American, and 11.8% were from other ethnic groups. Overall, 30.2% of women received mastectomy as initial treatment. Most women reported that they made the surgical decision (41.0%) or that the decision was shared (37.1%); 21.9% of patients reported that their surgeon made the decision with or without their input. Among white women, only 5.3% of patients whose surgeon made the decision received mastectomy compared with 16.8% of women who shared the decision and 27.0% of women who made the decision (P < .001, adjusted for clinical factors, predisposing factors, and number of surgeons visited). However, this association was not observed for African American women (Wald test 10.0, P = .041).
Most women reported that they made or shared the decision about surgical treatment. More patient involvement in decision making was associated with greater use of mastectomy. Racial differences in the association of involvement with receipt of treatment suggest that the decision-making process varies by racial groups.
乳房切除术的高发生率及显著的地区差异引发了人们对过度治疗以及未能让女性参与治疗决策的持续担忧。我们研究了乳腺癌女性患者参与决策与手术治疗类型之间的关系。
确定了2002年诊断为原位导管癌的所有女性以及年龄在79岁及以下浸润性乳腺癌女性的20%随机样本,这些患者被报告至底特律和洛杉矶监测、流行病学及最终结果登记处,并在接受手术治疗后不久进行了调查(回应率为77.4%;n = 1844)。
平均年龄为60.1岁;70.2%的女性为白人,18.0%为非裔美国人,11.8%来自其他种族群体。总体而言,30.2%的女性接受乳房切除术作为初始治疗。大多数女性报告称她们做出了手术决策(41.0%)或共同做出了决策(37.1%);21.9%的患者报告称其外科医生做出了决策,无论她们是否参与。在白人女性中,外科医生做出决策的患者中只有5.3%接受了乳房切除术,而共同做出决策的女性为16.8%,自己做出决策的女性为27.0%(经临床因素、易感因素及就诊外科医生数量校正后,P <.001)。然而,非裔美国女性未观察到这种关联(Wald检验值为10.0,P = 0.041)。
大多数女性报告称她们做出或共同做出了手术治疗决策。患者更多地参与决策与更多地使用乳房切除术相关。参与决策与接受治疗之间关联的种族差异表明决策过程因种族群体而异。